UHS
54
3
SWK
71
9
PM
39
-10
SWKS
56
4
VRSN
47
3
MAC
46
5
OMC
62
5
FAST
55
3
AON
71
6
PWR
54
-5
CL
50
3
FMC
44
8
CSCO
60
-3
VRTX
39
3
MAT
55
3
AVGO
42
-3
PYPL
43
10
ALL
70
3
DD
60
4
AAPL
55
2
UHS
54
3
SWK
71
9
PM
39
-10
SWKS
56
4
VRSN
47
3
MAC
46
5
OMC
62
5
FAST
55
3
AON
71
6
PWR
54
-5
CL
50
3
FMC
44
8
CSCO
60
-3
VRTX
39
3
MAT
55
3
AVGO
42
-3
PYPL
43
10
ALL
70
3
DD
60
4
AAPL
55
2
Financhill
Back

Goldman Sachs S&P 500 Premium Income ETF Vs. Cidara Therapeutics Industry Stock Comparison

Sell
47

GPIX
Goldman Sachs S&P 500 Premium Income ETF

Last Price:
$50.98
Seasonality Move:
3.3%
Buy
78

CDTX
Cidara Therapeutics

Last Price:
$63.02
Seasonality Move:
2.23%
Sell
47
Goldman Sachs S&P 500 Premium Income ETF (GPIX) is a Sell

Is Goldman Sachs S&P 500 Premium Income ETF a Buy, Sell or Hold?

  • The current Goldman Sachs S&P 500 Premium Income ETF [GPIX] share price is $50.98. The Score for GPIX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • GPIX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
78
Cidara Therapeutics (CDTX) is a Buy

Is Cidara Therapeutics a Buy, Sell or Hold?

  • The current Cidara Therapeutics [CDTX] share price is $63.25. The Score for CDTX is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GPIX Stock Price Chart

What is Goldman Sachs S&P 500 Premium Income ETF's stock price today?

  • The Goldman Sachs S&P 500 Premium Income ETF share price today is $50.98
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPIX is experiencing slight buying pressure.

CDTX Stock Price Chart

What is Cidara Therapeutics's stock price today?

  • The Cidara Therapeutics share price today is $63.25
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPIX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 13.29 Buy
Relative Strength Index (14 RSI): 63.77 Buy
Chaikin Money Flow: 24269 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.93 - 50.67) Buy
Bollinger Bands (100): (45.62 - 50.14) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 16.36 Buy
Relative Strength Index (14 RSI): 68.7 Buy
Chaikin Money Flow: 700144 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.5 - 64.06) Buy
Bollinger Bands (100): (17.06 - 51.62) Buy

GPIX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.4 Buy
20-day SMA: 50.4 Buy
50-day SMA: 49.63 Buy
200-day SMA: 48.71 Buy
8-day EMA: 48.07 Buy
20-day EMA: 35.25 Buy
50-day EMA: 19.21 Buy
200-day EMA: 5.7 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 62.15 Buy
20-day SMA: 61.7 Buy
50-day SMA: 47.71 Buy
200-day SMA: 27.34 Buy
8-day EMA: 59.28 Buy
20-day EMA: 43.54 Buy
50-day EMA: 23.74 Buy
200-day EMA: 7.04 Buy

Goldman Sachs S&P 500 Premium Income ETF Earnings Growth & GPIX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $4.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.92 per share, and a decrease next year of $1.83 per share.

Goldman Sachs S&P 500 Premium Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):